Use of the Symbion biventricular assist device in bridging to transplantation

Scott Lick, Jack G. Copeland, Richard G. Smith, Marilyn Cleavinger, Luis J. Rosado, Casey L. Huston, Gulshan K. Sethi, Thomas F. Molloy

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


From 1988 to 1991 13 patients received Symbion biventricular assist devices in attempts to bridge them to cardiac transplantation. All 7 of those who had cardiac transplants survived to hospital discharge. One death occurred 60 days after transplantation because of rejection. All other patients who received transplants are surviving. Implant times in this group varied from 10 to 164 days (mean, 55 days). There were two embolic neurologic events and two significant infections, and 2 of the survivors were dialyzed for reversible renal failure before transplantation. Of those who died on device support, 3 presented on centrifugal pump support. The three other deaths were caused by graft rejection, multiple organ failure, and multiple peripheral emboli. Biventricular assist devices optimally provide cardiac outputs of 4 to 5 L/min, can be quickly inserted often without requiring cardiopulmonary bypass, are easily explanted, and seem best suited for patients weighing less than 80 kg.

Original languageEnglish (US)
Pages (from-to)283-287
Number of pages5
JournalThe Annals of Thoracic Surgery
Issue number1
StatePublished - Jan 1993
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Use of the Symbion biventricular assist device in bridging to transplantation'. Together they form a unique fingerprint.

Cite this